New York, NY -- (SBWIRE) -- 12/11/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Hemispherx BioPharma, Inc (NYSEMKT:HEB), NII Holdings Inc (NASDAQ:NIHD), MONITISE PLC (OTCMKTS:MONIF), Barrick Gold Corporation (USA) (NYSE:ABX)
Hemispherx BioPharma, Inc (NYSEMKT:HEB) showed a volume of 6.73million shares by the end of last trade whereas the average volume of the stock remained 1.16million shares. The stock opened the session at $0.33 but then moved to $0.288. At that price, the stock showed a negative performance of -8.60%. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen and Alferon N Injection.
Will HEB Get Buyers Even After The Recent Rally? Find Out Here
NII Holdings Inc (NASDAQ:NIHD) opened the session at $2.44 and closed the session at $2.24. The stock showed a negative performance of -7.44% in previous trading session. NII Holdings, Inc. (NII Holdings) is a holding company for the operations of Nextel Communications, Inc. in selected International markets. The Company provides wireless communication services under the Nextel brand. It provides its services through operating companies located in Brazil, Mexico, Argentina, Peru and Chile, with its principal operations located in business centers and related transportation corridors of these countries. The Company’s networks utilize integrated digital enhanced network, or iDEN,
Has NIHD Found The Bottom And Ready To Gain Momentum? Find Out Here
MONITISE PLC (OTCMKTS:MONIF) opened the session at $0.91and closed the session at $0.912. The stock showed a negative performance of -0.72% in previous trading session. Traded with volume of 767,722.00 shares in the prior session and the average volume of the stock remained 1.10 million shares. The beta of the stock remained 1.11.
Why Should Investors Buy MONIF After the Recent Fall? Just Go Here and Find Out
Barrick Gold Corporation (USA) (NYSE:ABX) the stock advanced 5.44% and finished the session at $16.87. Traded with volume of 21.75 million shares in the prior session and the average volume of the stock remained 20.67 million shares. The beta of the stock remained 0.45. Barrick Gold Corporation (Barrick) is engaged in the production and sale of gold, as well as related activities, such as exploration and mine development. Barrick also produces copper, principally from the Zaldivar and Lumwana mines and holds other interests, including a nickel development project located in Africa. Barrick’s business is organized into seven primary operating segments: four regional gold businesses, a global copper business unit, an oil and gas business,
Will ABX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)